New treatment for tackling plaque psoriasis

Secukinumab (Cosentyx) is licensed for the treatment of moderate to severe plaque psoriasis. Here, Steve Chaplin presents the clinical data relating to its efficacy and Drs Susan O’Gorman and Trevor Markham discuss its place in therapy.

New treatment for tackling plaque psoriasis

Add yours ↓
Web design and marketing agency Leamington Spa